Inflammation in Cardiac Amyloidosis: Prognostic Marker or Therapeutic Target?

European Journal of Heart Failure- United States

doi 10.1002/ejhf.1062

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Inflammation as a Therapeutic Target in Atherosclerosis

Journal of Clinical Medicine
2019English

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Intramyocardial Inflammation Predicts Adverse Outcome in Patients With Cardiac AL Amyloidosis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Unmasking a New Prognostic Marker and Therapeutic Target From the GDNF-RET/PIT1/p14ARF/p53 Pathway in Acromegaly

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy